Analytical Data
-
Gene name
sdrE
- Application
-
Alternative Names
sdrE; SAV0563Serine-aspartate repeat-containing protein E
-
Species
Staphylococcus aureus
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q932F7
-
Expression Region
53-601aa
-
Molecular Weight
64.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of sdrE recombinant protein is rooted in the broader context of microbial pathogenesis and immune evasion mechanisms. sdrE (serine-aspartate repeat protein E) is a surface protein found in certain pathogenic strains of Staphylococcus aureus, a leading cause of various infections in humans, ranging from skin infections to more serious conditions like pneumonia and septicemia. This protein plays a critical role in bacterial adhesion, biofilm formation, and evasion of the host immune response, making it an important target for understanding the virulence of S. aureus. Research into sdrE aims to elucidate its structure-function relationship, the molecular pathways it influences, and its interactions with host immune components. By employing recombinant DNA technology, scientists can produce sdrE in a controlled laboratory setting, facilitating in-depth studies of its biological functions and potential as a vaccine candidate or therapeutic target. Furthermore, investigating the role of sdrE in biofilm formation enhances our understanding of chronic infections, which are often resistant to conventional antibiotic treatments. Overall, the exploration of sdrE recombinant protein not only contributes to the field of microbiology and infectious diseases but also holds implications for developing novel interventions against multidrug-resistant strains of bacteria.
